As of 2025-07-04, the Intrinsic Value of AKKO Invest Nyrt (AKKO.BD) is 378.37 HUF. This AKKO.BD valuation is based on the model Discounted Cash Flows (Growth Exit 10Y). With the current market price of 288.00 HUF, the upside of AKKO Invest Nyrt is 31.40%.
The range of the Intrinsic Value is 236.15 - 597.49 HUF
Based on its market price of 288.00 HUF and our intrinsic valuation, AKKO Invest Nyrt (AKKO.BD) is undervalued by 31.40%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | (117.38) - 47.04 | (53.27) | -118.5% |
| DCF (Growth 10y) | 236.15 - 597.49 | 378.37 | 31.4% |
| DCF (EBITDA 5y) | 1,682.63 - 2,402.30 | 2,023.55 | 602.6% |
| DCF (EBITDA 10y) | 1,392.24 - 2,232.03 | 1,774.39 | 516.1% |
| Fair Value | 721.96 - 721.96 | 721.96 | 150.68% |
| P/E | 438.95 - 892.36 | 651.66 | 126.3% |
| EV/EBITDA | 630.98 - 3,238.05 | 1,731.29 | 501.1% |
| EPV | (324.52) - (344.33) | (334.42) | -216.1% |
| DDM - Stable | 144.66 - 290.08 | 217.37 | -24.5% |
| DDM - Multi | 492.17 - 792.08 | 609.24 | 111.5% |
| Market Cap (mil) | 11,528.64 |
| Beta | 0.87 |
| Outstanding shares (mil) | 40.03 |
| Enterprise Value (mil) | 21,266.64 |
| Market risk premium | 7.88% |
| Cost of Equity | 13.47% |
| Cost of Debt | 7.63% |
| WACC | 13.15% |